IGHVII-781: A Potential Drug Target and Biomarker for Various Diseases

Target Name: IGHVII-78-1

NCBI ID: G28356

IGHVII-78-1

Other Name(s): IGHVII781 | 4-78.1P | Immunoglobulin heavy variable (II)-78-1 (pseudogene) | immunoglobulin heavy variable (II)-78-1 (pseudogene)

IGHVII-781: A Potential Drug Target and Biomarker for Various Diseases

IGHVII-78-1 (IGHVII781) is a glycoprotein that is expressed in most tissues of the body. It is a member of the interleukin-7 (IL-7) family and is involved in the regulation of inflammation and immune responses. IGHVII- 781 has been identified as a potential drug target and a biomarker for various diseases, including cancer, autoimmune disorders, and inflammatory diseases.

The IGHVII-781 protein is a transmembrane protein that is expressed in various tissues of the body, including the spleen, thymus, lungs, heart, kidneys, and intestines. It is a glycoprotein that consists of a constant region, a variable region, and an C-terminal hypervariable region (HVR). The constant region of IGHVII-781 consists of a single alpha-helical loop and a single beta-sheet, while the variable region consists of multiple alpha-helices that are involved in the regulation of cytokine signaling and inflammation. The C-terminal HVR consists of a unique farnesylated cysteine 鈥嬧?媟esidue that is involved in the regulation of protein stability and functions.

IGHVII-781 is involved in the regulation of cytokine signaling and inflammation. It has been shown to play a role in the regulation of T cell responses, including cell proliferation, differentiation, and selection. IGHVII-781 has also been shown to regulate the production of pro-inflammatory cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha).

IGHVII-781 has also been shown to be involved in the regulation of immune cell function, including the regulation of B cell proliferation and differentiation. It has been shown to play a role in the regulation of antibody production and memory, as well as the regulation of immune cell survival and apoptosis.

IGHVII-781 has been shown to be involved in the regulation of inflammatory responses. It has been shown to play a role in the regulation of inflammation and immune cell responses to bacterial and viral infections. IGHVII-781 has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1, as well as the regulation of the production of anti-inflammatory cytokines, such as IL-10.

In conclusion, IGHVII-781 is a glycoprotein that is involved in the regulation of inflammation and immune responses. It has been identified as a potential drug target and a biomarker for various diseases, including cancer, autoimmune disorders, and inflammatory diseases. Further research is needed to fully understand the role of IGHVII-781 in these diseases and to develop effective treatments.

Protein Name: Immunoglobulin Heavy Variable (II)-78-1 (pseudogene)

The "IGHVII-78-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHVII-78-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets